ForSight Robotics Expands Leadership Team with Appointment of Sharon Levita As CFO

Seasoned medical device executive Sharon Levita to join the company

ForSight Robotics, a pioneer of robotic eye surgery, announced today the appointment of Sharon Levita as Chief Financial Officer (CFO), effective September 1, 2023. Levita will lead ForSight Robotics’ strategic and financial operations, focusing on driving business strategies, expanding strategic partnerships, and managing financial and growth objectives.

Levita brings over 20 years of industry experience working with private and publicly-listed (NASDAQ and TASE) companies. Most recently, Levita served as Medtronic’s Business Development and Strategy Leader at the company’s Cranial and Spinal Technologies operating unit, and as VP of Business Operations and Medtronic Site Lead (formerly robotic spine surgery company Mazor Robotics) in Israel. Prior to this, Levita served as CFO and VP of Business Operations at Mazor Robotics for over a decade and led the company’s $1.6 billion acquisition by Medtronic in 2018. Her previous experience includes various leadership roles at medical laser company Lumenis and at KPMG Hungary.

“Sharon is a proven leader, dedicated to driving forward healthcare innovation,” said Dr. Joseph Nathan, ForSight Robotics co-founder, president, and chief medical officer. “Her expertise and vast management experience in global medical technology companies, from developing successful go-to-market strategies to expanding global partnerships, are unparalleled and aligned with the company’s vision. We are thrilled to welcome Sharon to our team as we continue advancing in the development of our ORYOM Surgical Robotics Platform.”

“This is such an exciting time to join ForSight Robotics,” said Sharon Levita. “The company has significant potential to help millions of patients around the world. I value its mission to democratize quality surgical eye care and am eager to work together with the world-class team to strengthen the company’s forward momentum and together, have a global impact.”

In the past year, ForSight Robotics raised a record $55 million Series A funding round, doubled in size to 50 employees, and expanded its leadership team with the appointments of Dr. Yaron Levinson as Head of Product and Ran Mendelewicz as Head of Robotics. Levinson joined the company following over a decade in the surgical robotics industry, most recently as VP R&D at surgical robotics company Momentis Surgical, where he supported regulatory processes to receive FDA approval for the company’s robotic system. Mendelewicz joined ForSight Robotics following 20 years in the medical device industry, most recently as VP R&D at intraocular implant company Nano Retina.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.